Logo
North America Drug Discovery Market 2020-2030

North America Drug Discovery Market 2020-2030

Bonafide Trust 02-02-2022 117 Pages
Region : North America Category : Lifescience Healthcare

North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents. Highlighted with 27 tables and 60 figures, this 117-page report “North America Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19). In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America drug discovery market in every aspect of the classification from perspectives of Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country. Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Small Molecule Drugs • Biologic Drugs Based on Service, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Medicinal Chemical Services • Biological Services • Drug Metabolism and Pharmacokinetics (DMPK) Services • Other Pharmaceutical Services Based on Process, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Target Selection • Target Validation • Hit-To-Lead Identification • Lead Optimization • Candidate Validation Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • High Throughput Screening • Combinatorial Chemistry • Pharmacogenomics and Pharmacogenetics • Nanotechnology • Bioanalytical Instruments • Biochips • Bioinformatics • Other Technologies Based on Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Oncology • Neurology • Infectious and Immune System Diseases • Digestive System Diseases • Cardiovascular Diseases • Diabetes • Respiratory Disease • Other Therapeutic Areas Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Pharmaceutical Companies • Contract Research Organizations (CROs) • Research Institutes • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Drug Type, Service, and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories Inc. Agilent Technologies Inc. Astrazeneca plc Bayer AG Charles River Laboratories International Inc. Eli Lilly and Company F. Hoffmann-La Roche Ltd GlaxoSmithKline PLC Merck & Co. Inc. Novartis AG Pfizer Inc. Shimadzu Corp Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services